NCT05083208 2025-12-02
PI3Kδ Inhibitor Parsaclisib Combined With Chidamide for the Treatment of Relapsed/Refractory Peripheral T-cell Lymphoma
Henan Cancer Hospital
Phase 1 Terminated
Clinical Trials
7 trialsNCT02618109 2022-10-03
LABMI
University Hospital, Angers
Phase 4 Terminated
NCT04321850 2020-08-04
Impact of the Use of Zinc in the Prevention of Oral Mucositis in Pediatric Patients With Lymphoblastic Acute Leukemia.
National Institute of Pediatrics, Mexico
Phase NA Terminated
NCT01642563 2015-07-28
IPTAS
Centro Nazionale Sangue
Phase 3 Terminated
NCT00432419 2011-12-22
Therapeutic Intensification of HIV-associated Non-Hodgkin's Lymphoma by Peripheral Blood Cell Transplantation Following Chemotherapy.
French National Agency for Research on AIDS and Viral Hepatitis
Phase 1/2 Terminated
NCT00127569 2007-01-12
Rituximab in the Treatment of HIV Associated Multicentric Castleman Disease Dependent on Chemotherapy
French National Agency for Research on AIDS and Viral Hepatitis
Phase 2 Terminated
NCT00126243 2005-08-17
Efficacy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With HIV Associated Non-Hodgkin's Lymphoma
French National Agency for Research on AIDS and Viral Hepatitis
Phase 2 Terminated